E-mail a Wiley Online Library Link

Christopher R. Heier, Jesse M. Damsker, Qing Yu, Blythe C. Dillingham, Tony Huynh, Jack H. Van der Meulen, Arpana Sali, Brittany K. Miller, Aditi Phadke, Luana Scheffer, James Quinn, Kathleen Tatem, Sarah Jordan, Sherry Dadgar, Olga C. Rodriguez, Chris Albanese, Michael Calhoun, Heather Gordish-Dressman, Jyoti K. Jaiswal, Edward M. Connor, John M. McCall, Eric P. Hoffman, Erica K. M. Reeves and Kanneboyina Nagaraju VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects EMBO Molecular Medicine 5

Version of Record online: 9 SEP 2013 | DOI: 10.1002/emmm.201302621

Thumbnail image of graphical abstract

Through studying the molecular mechanisms of glucocorticoids in Duchenne Muscular Dystrophy, the authors developed VBP15 as a novel oral drug with great therapeutic potentials in mdx mice.VBP15 acts like steroids, yet lacks their side effects.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field